Accelerating Precision Medicine Through Illumina’s Global Ecosystem

• Expand global patient access through Illumina’s commercial and regulatory expertise
• Enable custom CDx development through Illumina’s network of assay development partners
• Utilise TruSight Oncology Comprehensive to drive biomarker identification, clinical validation, and oncology patient access throughout the world

Speakers:

Ali Kuraishy

Senior Director, Head of Clinical Business Development

Illumina